Use of complementary therapies in patients with Parkinson's disease in Singapore
Identifieur interne : 003129 ( Main/Exploration ); précédent : 003128; suivant : 003130Use of complementary therapies in patients with Parkinson's disease in Singapore
Auteurs : Louis C. S. Tan [Singapour] ; Puay-Ngoh Lau [Singapour] ; Roland Dominic G. Jamora [Singapour] ; Edwin S. Y. Chan [Singapour]Source :
- Movement Disorders [ 0885-3185 ] ; 2006-01.
Descripteurs français
- Pascal (Inist)
- Wicri :
English descriptors
- KwdEn :
- Acupuncture, Aged, Alternative medicine, Asian Continental Ancestry Group, Combined Modality Therapy, Complementary Therapies (utilization), Cross-Cultural Comparison, Female, Follow-Up Studies, Human, Humans, Male, Middle Aged, Nervous system diseases, Parkinson Disease (epidemiology), Parkinson Disease (ethnology), Parkinson Disease (therapy), Parkinson disease, Parkinson's disease, Singapore, Socioeconomic Factors, Survival Analysis, Treatment, Treatment Outcome, Vitamin, acupuncture, alternative medicine, complementary therapies, traditional medicine, vitamins.
- MESH :
- geographic : Singapore.
- epidemiology : Parkinson Disease.
- ethnology : Parkinson Disease.
- therapy : Parkinson Disease.
- utilization : Complementary Therapies.
- Aged, Asian Continental Ancestry Group, Combined Modality Therapy, Cross-Cultural Comparison, Female, Follow-Up Studies, Humans, Male, Middle Aged, Socioeconomic Factors, Survival Analysis, Treatment Outcome.
Abstract
To determine the frequency and spectrum of complementary therapy (CT) use and its association with sociodemographic or disease‐specific characteristics among Asian patients with Parkinson's disease (PD) in Singapore, we interviewed 159 patients using a structured questionnaire. Sixty‐one percent (95% CI = 55–67) of participants used at least one type of CT for PD, of which the most common were traditional medicine, acupuncture, and vitamins/health supplements. Among CT users, 40% (95% CI = 32–48) subjectively reported some improvement of their symptoms. However, only 16% informed their physicians of their use of CT. Due to unequal follow‐up times, a survival analysis approach was adopted for statistical analysis. The rate of starting CT use was 1.2/100 person months. At 3 years after PD diagnosis, 48% had started using CT. Among a subgroup of participants, those with a baseline Unified Parkinson's Disease Rating Scale motor score of more than 16 were 2.5 times more likely to use CT compared to those with a baseline score of 16 or less (P = 0.031; 95% CI = 1.1–5.8). CT use was not associated with age of onset of PD or other sociodemographic factors. The use of CT is high among Asian PD patients. Patients with more severe motor dysfunction at onset are more likely to use CT. © 2005 Movement Disorder Society
Url:
DOI: 10.1002/mds.20662
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 002709
- to stream Istex, to step Curation: 002709
- to stream Istex, to step Checkpoint: 001B88
- to stream PubMed, to step Corpus: 002F07
- to stream PubMed, to step Curation: 002F07
- to stream PubMed, to step Checkpoint: 002A37
- to stream Ncbi, to step Merge: 001405
- to stream Ncbi, to step Curation: 001405
- to stream Ncbi, to step Checkpoint: 001405
- to stream Main, to step Merge: 004442
- to stream PascalFrancis, to step Corpus: 001C81
- to stream PascalFrancis, to step Curation: 001040
- to stream PascalFrancis, to step Checkpoint: 001851
- to stream Main, to step Merge: 004946
- to stream Main, to step Curation: 003129
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Use of complementary therapies in patients with Parkinson's disease in Singapore</title>
<author><name sortKey="Tan, Louis C S" sort="Tan, Louis C S" uniqKey="Tan L" first="Louis C. S." last="Tan">Louis C. S. Tan</name>
</author>
<author><name sortKey="Lau, Puay Goh" sort="Lau, Puay Goh" uniqKey="Lau P" first="Puay-Ngoh" last="Lau">Puay-Ngoh Lau</name>
</author>
<author><name sortKey="Jamora, Roland Dominic G" sort="Jamora, Roland Dominic G" uniqKey="Jamora R" first="Roland Dominic G." last="Jamora">Roland Dominic G. Jamora</name>
</author>
<author><name sortKey="Chan, Edwin S Y" sort="Chan, Edwin S Y" uniqKey="Chan E" first="Edwin S. Y." last="Chan">Edwin S. Y. Chan</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:F36DBA7B551DD3532E633D4BF1B469A3144F749C</idno>
<date when="2006" year="2006">2006</date>
<idno type="doi">10.1002/mds.20662</idno>
<idno type="url">https://api.istex.fr/document/F36DBA7B551DD3532E633D4BF1B469A3144F749C/fulltext/pdf</idno>
<idno type="wicri:Area/Istex/Corpus">002709</idno>
<idno type="wicri:Area/Istex/Curation">002709</idno>
<idno type="wicri:Area/Istex/Checkpoint">001B88</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Tan L:use:of:complementary</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:16108030</idno>
<idno type="wicri:Area/PubMed/Corpus">002F07</idno>
<idno type="wicri:Area/PubMed/Curation">002F07</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002A37</idno>
<idno type="wicri:Area/Ncbi/Merge">001405</idno>
<idno type="wicri:Area/Ncbi/Curation">001405</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">001405</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Tan L:use:of:complementary</idno>
<idno type="wicri:Area/Main/Merge">004442</idno>
<idno type="wicri:source">INIST</idno>
<idno type="RBID">Pascal:06-0135501</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001C81</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001040</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">001851</idno>
<idno type="wicri:doubleKey">0885-3185:2006:Tan L:use:of:complementary</idno>
<idno type="wicri:Area/Main/Merge">004946</idno>
<idno type="wicri:Area/Main/Curation">003129</idno>
<idno type="wicri:Area/Main/Exploration">003129</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Use of complementary therapies in patients with Parkinson's disease in Singapore</title>
<author><name sortKey="Tan, Louis C S" sort="Tan, Louis C S" uniqKey="Tan L" first="Louis C. S." last="Tan">Louis C. S. Tan</name>
<affiliation wicri:level="1"><country xml:lang="fr">Singapour</country>
<wicri:regionArea>Department of Neurology, National Neuroscience Institute</wicri:regionArea>
<wicri:noRegion>National Neuroscience Institute</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Lau, Puay Goh" sort="Lau, Puay Goh" uniqKey="Lau P" first="Puay-Ngoh" last="Lau">Puay-Ngoh Lau</name>
<affiliation wicri:level="1"><country xml:lang="fr">Singapour</country>
<wicri:regionArea>Department of Nursing Administration, National Neuroscience Institute</wicri:regionArea>
<wicri:noRegion>National Neuroscience Institute</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Jamora, Roland Dominic G" sort="Jamora, Roland Dominic G" uniqKey="Jamora R" first="Roland Dominic G." last="Jamora">Roland Dominic G. Jamora</name>
<affiliation wicri:level="1"><country xml:lang="fr">Singapour</country>
<wicri:regionArea>Department of Neurology, National Neuroscience Institute</wicri:regionArea>
<wicri:noRegion>National Neuroscience Institute</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Chan, Edwin S Y" sort="Chan, Edwin S Y" uniqKey="Chan E" first="Edwin S. Y." last="Chan">Edwin S. Y. Chan</name>
<affiliation wicri:level="1"><country xml:lang="fr">Singapour</country>
<wicri:regionArea>Clinical Trials and Epidemiology Research Unit</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2006-01">2006-01</date>
<biblScope unit="vol">21</biblScope>
<biblScope unit="issue">1</biblScope>
<biblScope unit="page" from="86">86</biblScope>
<biblScope unit="page" to="89">89</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">F36DBA7B551DD3532E633D4BF1B469A3144F749C</idno>
<idno type="DOI">10.1002/mds.20662</idno>
<idno type="ArticleID">MDS20662</idno>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acupuncture</term>
<term>Aged</term>
<term>Alternative medicine</term>
<term>Asian Continental Ancestry Group</term>
<term>Combined Modality Therapy</term>
<term>Complementary Therapies (utilization)</term>
<term>Cross-Cultural Comparison</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Human</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Nervous system diseases</term>
<term>Parkinson Disease (epidemiology)</term>
<term>Parkinson Disease (ethnology)</term>
<term>Parkinson Disease (therapy)</term>
<term>Parkinson disease</term>
<term>Parkinson's disease</term>
<term>Singapore</term>
<term>Socioeconomic Factors</term>
<term>Survival Analysis</term>
<term>Treatment</term>
<term>Treatment Outcome</term>
<term>Vitamin</term>
<term>acupuncture</term>
<term>alternative medicine</term>
<term>complementary therapies</term>
<term>traditional medicine</term>
<term>vitamins</term>
</keywords>
<keywords scheme="MESH" type="geographic" xml:lang="en"><term>Singapore</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="ethnology" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="utilization" xml:lang="en"><term>Complementary Therapies</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Aged</term>
<term>Asian Continental Ancestry Group</term>
<term>Combined Modality Therapy</term>
<term>Cross-Cultural Comparison</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Socioeconomic Factors</term>
<term>Survival Analysis</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Acupuncture</term>
<term>Homme</term>
<term>Médecine parallèle</term>
<term>Parkinson maladie</term>
<term>Singapour</term>
<term>Système nerveux pathologie</term>
<term>Traitement</term>
<term>Vitamine</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>Singapour</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Homme</term>
<term>Vitamine</term>
</keywords>
</textClass>
<langUsage><language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">To determine the frequency and spectrum of complementary therapy (CT) use and its association with sociodemographic or disease‐specific characteristics among Asian patients with Parkinson's disease (PD) in Singapore, we interviewed 159 patients using a structured questionnaire. Sixty‐one percent (95% CI = 55–67) of participants used at least one type of CT for PD, of which the most common were traditional medicine, acupuncture, and vitamins/health supplements. Among CT users, 40% (95% CI = 32–48) subjectively reported some improvement of their symptoms. However, only 16% informed their physicians of their use of CT. Due to unequal follow‐up times, a survival analysis approach was adopted for statistical analysis. The rate of starting CT use was 1.2/100 person months. At 3 years after PD diagnosis, 48% had started using CT. Among a subgroup of participants, those with a baseline Unified Parkinson's Disease Rating Scale motor score of more than 16 were 2.5 times more likely to use CT compared to those with a baseline score of 16 or less (P = 0.031; 95% CI = 1.1–5.8). CT use was not associated with age of onset of PD or other sociodemographic factors. The use of CT is high among Asian PD patients. Patients with more severe motor dysfunction at onset are more likely to use CT. © 2005 Movement Disorder Society</div>
</front>
</TEI>
<affiliations><list><country><li>Singapour</li>
</country>
</list>
<tree><country name="Singapour"><noRegion><name sortKey="Tan, Louis C S" sort="Tan, Louis C S" uniqKey="Tan L" first="Louis C. S." last="Tan">Louis C. S. Tan</name>
</noRegion>
<name sortKey="Chan, Edwin S Y" sort="Chan, Edwin S Y" uniqKey="Chan E" first="Edwin S. Y." last="Chan">Edwin S. Y. Chan</name>
<name sortKey="Jamora, Roland Dominic G" sort="Jamora, Roland Dominic G" uniqKey="Jamora R" first="Roland Dominic G." last="Jamora">Roland Dominic G. Jamora</name>
<name sortKey="Lau, Puay Goh" sort="Lau, Puay Goh" uniqKey="Lau P" first="Puay-Ngoh" last="Lau">Puay-Ngoh Lau</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003129 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003129 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= MovDisordV3 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:F36DBA7B551DD3532E633D4BF1B469A3144F749C |texte= Use of complementary therapies in patients with Parkinson's disease in Singapore }}
![]() | This area was generated with Dilib version V0.6.23. | ![]() |